Fullerene (C60) for Hyperpigmentation: The “Radical Sponge” Nanomaterial Rewriting 2026 Brightening Science

As the brightening category matures beyond tyrosinase inhibition alone, oxidative-stress control has emerged as a first-class mechanism in hyperpigmentation science. No material embodies that shift better than fullerene — a spherical carbon nanomolecule whose ability to neutralize free radicals without being consumed has quietly made it a premium active in Japanese and Korean brightening formulations. This article examines the mechanism, the clinical evidence, and the practical formulation science behind C60 for hyperpigmentation.

What Fullerene (C60) Actually Is

Fullerene, specifically buckminsterfullerene (C60), is an allotrope of carbon comprising 60 atoms arranged in a hollow, truncated-icosahedron cage — the “soccer ball” structure discovered in 1985 by Kroto, Curl and Smalley, work recognised with the 1996 Nobel Prize in Chemistry. The molecule is roughly 0.7 nm in diameter, lipophilic in its native state, and exceptionally stable. That stability, combined with an unusual electron-rich cage, is the basis of its cosmetic function.

Mechanism: A “Radical Sponge,” Not a Classical Antioxidant

Conventional antioxidants such as L-ascorbic acid and tocopherol neutralise a radical by donating an electron, and are themselves oxidised and spent in the process. Fullerene behaves differently. Its cage absorbs and quenches reactive oxygen species (ROS) without structural breakdown, allowing a single molecule to intercept multiple radicals. This catalytic, non-sacrificial behaviour is why C60 is often described as a “radical sponge.” Published in-vitro comparisons place its per-molecule antioxidant capacity far above vitamin C (commonly cited as ~172×, though lab conditions overstate real-skin performance).

How Fullerene Suppresses Melanogenesis

UV exposure generates ROS that act as secondary messengers: they activate the p38 MAPK cascade, which phosphorylates and stabilises MITF, the master transcription factor driving tyrosinase, TRP-1 and TRP-2 expression. Because fullerene quenches ROS upstream, it dampens the entire oxidative signalling arm that amplifies pigment production.

The pivotal mechanistic study (Xiao, Matsubayashi & Miwa, Archives of Dermatological Research, 2007; 299:245–257) used a water-soluble polyvinylpyrrolidone (PVP)-wrapped C60 derivative (“Radical Sponge”). It markedly scavenged UVA-induced intracellular ROS in human melanocytes, significantly inhibited UVA-promoted melanogenesis in normal human epidermal melanocytes and HMV-II melanoma cells, and — in human skin explants — reduced melanin content and the number of UVA-increased melanosomes. Notably, it outperformed arbutin and L-ascorbic acid on both tyrosinase activity and melanin quantification, acting principally by downregulating tyrosinase expression rather than direct competitive inhibition.

Clinical Evidence

• 8-week human trial (1% Radical Sponge gel, n=18 women, mean age 42.2): twice-daily facial application significantly reduced the melanin index versus baseline; in a paired UV-induced tanning model, the fullerene-treated site showed a significantly lower melanin index than the vehicle-treated site — a direct brightening readout, not merely an antioxidant surrogate.
• Water-soluble fullerene–sodium hyaluronate (MHAF60), Fine Chemicals 2021: EPR spectroscopy showed radical-quenching capacity superior to PVP-wrapped fullerene, vitamin C and water-soluble astaxanthin; in HEK-A keratinocytes it repaired oxidative damage 1.2–1.6× more effectively; in a zebrafish model it significantly inhibited melanin synthesis and inflammation.
• Pore/appearance endpoints: a 1% Radical Sponge lotion reduced conspicuous facial pores by 17.6% (p<0.05) at 8 weeks, consistent with downstream remodelling benefits of sustained antioxidant protection.

Interpretation: the evidence base for C60 in pigmentation is mechanistic and early-clinical, smaller than that for niacinamide or retinol, and most human data originate from Japanese research groups. It is best positioned as an evidence-supported antioxidant pillar of a brightening regimen, not a head-to-head hydroquinone replacement.

Formulation Science: Delivering a Water-Insoluble Nanomolecule

Native C60 is insoluble in water and poorly dispersible, so delivery chemistry is the whole game. Commercially validated approaches include:

• PVP-wrapped fullerene (“Radical Sponge”): water-soluble polymer complex, the form used in most clinical work.
• Fullerene–sodium hyaluronate (MHAF60): water-soluble, with superior radical quenching in head-to-head EPR testing.
• LipoFullerene in squalane: oil-soluble route (INCI: Fullerenes, Squalane), suited to anhydrous or oil-phase incorporation.
• Encapsulation / nanosuspension: for suspended delivery in emulsions, with photoprotection of the dispersed phase.

Practical parameters: effective use levels typically start around 250 ppm, with clinical benefit demonstrated at 1% of the PVP-wrapped complex. Fullerene is thermally robust but should be protected from prolonged direct light, and finished products benefit from opaque or airless packaging. It is compatible with — and can stabilise — L-ascorbic acid, and pairs well with niacinamide, tranexamic acid and arbutin for multi-pathway brightening. Always pair any brightening claim with broad-spectrum UV protection; fullerene is an antioxidant, not a UV filter.

Safety and Regulatory Status

Published topical use has not raised a major dermatitis signal, and multiple human studies report no significant irritation. Formulators should nevertheless track the regulatory picture: in 2023 the EU Scientific Committee on Consumer Safety (SCCS/1649/23) concluded it could not establish the safety of fullerenes and hydroxylated fullerenes in cosmetics, citing data gaps on genotoxicity and long-term nanomaterial behaviour. In the EU this triggers nanomaterial notification obligations and continued scrutiny; verify current status per market before commercialising.

Where Fullerene Fits

Fullerene answers a specific 2026 consumer demand: brightening for sensitive and melanin-rich skin that cannot tolerate aggressive actives. As an antioxidant-led active that suppresses pigment signalling upstream — and visibly reduces melanin index in controlled human use — it complements rather than competes with tyrosinase inhibitors. For a differentiated brightening serum, a defensible architecture is: a water-soluble fullerene complex for oxidative control, plus a tyrosinase inhibitor (e.g. alpha-arbutin or tranexamic acid), plus niacinamide for melanosome-transfer blockade, in a barrier-supportive base.

References

1. Xiao L, Matsubayashi K, Miwa N. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues. Archives of Dermatological Research. 2007;299(5–6):245–257.
2. Radical Sponge (PVP-wrapped fullerene): brightening effect via control of free radicals — 8-week clinical evaluation, 1% gel. Personal Care Magazine. 2011.
3. High-safety fullerene cosmetic raw materials and their whitening, anti-inflammatory and repairing effects (MHAF60 / PPF60). Fine Chemicals (精细化工). 2021.
4. SCCS/1649/23. Opinion on fullerenes, hydroxylated fullerenes. Scientific Committee on Consumer Safety, European Commission. 2023.
5. Nafisi S, Maibach HI. Fullerene and derivatives in cosmetic science. In: Cosmetic Science and Technology. 2017.